Results 11 to 20 of about 1,958,350 (306)

Free acquisition of psychotropic drugs by the Brazilian adult population and presence on the National List of Essential Medicines [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2022
The aims of the present study were to estimate the free-of-charge acquisition of psychotropic drugs among Brazilian adults; analyze the distribution of psychotropics according to their presence on the Relação Nacional de Medicamentos Essenciais (RENAME ...
Patrícia Silveira Rodrigues, Priscila Maria Stolses Bergamo Francisco, Andréia Turmina Fontanella, Karen Sarmento Costa   +3 more
doaj   +1 more source

Selection of psychotropic medications for the primary health care essential medicine list: Rationale and process

South African Journal of Psychiatry, 2018
Introduction: Equitable access to essential psychotropic medicines at primary level is fundamental to universal health coverage for mental health. It relies upon rational selection, affordable pricing, financial protection and consistent supply systems ...
Lesley J. Robertson, Renee De Waal, Trudy D. Leong   +2 more
doaj   +1 more source

Drug treatment of hypertension: focus on vascular health [PDF]

, 2016
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a growing health burden. Serious cardiovascular complications result from target organ damage including cerebrovascular disease, heart failure, ischaemic heart
Cameron, Alan C., Lang, Ninian N., Touyz, Rhian M.   +2 more
core   +1 more source

Cost-analysis of the WHO Essential Medicines List in A Resource-Limited Setting: Experience from A District Hospital in India [PDF]

Journal of Clinical and Diagnostic Research, 2014
The World Health Organization (WHO) has been publishing the essential medicines list (EML) since 1977. The EML includes the most efficacious, safe and cost-effective drugs for the most relevant public health conditions worldwide. The WHO performs a cost-
Gerardo Alvarez-Uria, Dixon Thomas, Seeba Zachariah, Rajarajeshwari Byram, Shanmugamari Kannan   +4 more
doaj   +1 more source

Novel cruzain inhibitors for the treatment of Chagas' disease. [PDF]

, 2012
The protozoan parasite Trypanosoma cruzi, the etiological agent of Chagas' disease, affects millions of individuals and continues to be an important global health concern.
Arkin, Michelle R, Doak, Allison, Durrant, Jacob D, Keränen, Henrik, McCammon, J Andrew, Ratnam, Joseline, Rogers, Kathleen E   +6 more
core   +1 more source

Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia [PDF]

, 2008
3openA.
Ania, Campbell, Cortelazzo, Cortelazzo, Egger, Finazzi, Finelli, Harrison, Higgins, Higgins, Landolfi, Landolfi, Landolfi, Lau, Maclure, Marchioli, Mesa, Parmar, Passamonti, Rocca, Tartaglia, Vardiman   +21 more
core   +1 more source

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

BMC Health Services Research, 2021
Background Cryptococcal meningitis in HIV-infected patients in sub-Saharan Africa accounts for three-quarters of the global cases and 135,000 deaths per annum. Current treatment includes the use of fluconazole and amphotericin B.
Jacqui Miot, Trudy Leong, Simbarashe Takuva, Andrew Parrish, Halima Dawood   +4 more
doaj   +1 more source

Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications [PDF]

, 2013
This article is made available through the Brunel Open Access Publishing Fund. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.CLU (clusterin) is a tumor suppressor gene that we have previously shown to be negatively modulated ...
Cantilena, S, Chayka, O, Corvetta, D, D'Acunto, CW, Gherardi, S, Perini, G, Piotrowska, I, Sala, A, Valli, E   +8 more
core   +1 more source

Divergent strategy for the synthesis of α-aryl-substituted fosmidomycin analogues [PDF]

, 2007
Fosmidomycin is the first representative of a new class of antimalarial drugs acting through inhibition of 1-deoxy-D-xylulose 5-phosphate ( DOXP) reductoisomerase (DXR), an essential enzyme in the non-mevalonate pathway for the synthesis of isoprenoids ...
Devreux, Vincent, Jomaa, Hassan, Rozenski, Jef, Van Calenbergh, Serge, Van der Eycken, Johan, Wiesner, Jochen   +5 more
core   +2 more sources

Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators

Global Health Action, 2020
Background Access to essential medicines for the world’s poor and vulnerable has made little progress since 2000, except for a few specific medicines such as antiretrovirals for HIV/AIDS.
Katrina Perehudoff
doaj   +1 more source